Expression of the IGF‑1Ea isoform in human placentas from third trimester normal and idiopathic intrauterine growth restriction singleton pregnancies: Correlations with clinical and histopathological parameters

Fasoulopoulos,Apostolos; Varras,Michail; Varra,Fani-Niki; Philippou,Anastasios; Myoteri,Despina; Varra,Viktoria-Konstantina; Kouroglou,Evgenia; Gryparis,Alexandros; Papadopetraki,Argyro; Vlachos,Iakovos; Papadopoulos,Konstantinos; Koutsilieris,Michael; Konstantinidou,Anastasia Evangelia

doi:10.3892/mmr.2025.13434

Expression of the IGF‑1Ea isoform in human placentas from third trimester normal and idiopathic intrauterine growth restriction singleton pregnancies: Correlations with clinical and histopathological parameters

Authors:
- Apostolos Fasoulopoulos
- Michail Varras
- Fani-Niki Varra
- Anastasios Philippou
- Despina Myoteri
- Viktoria-Konstantina Varra
- Evgenia Kouroglou
- Alexandros Gryparis
- Argyro Papadopetraki
- Iakovos Vlachos
- Konstantinos Papadopoulos
- Michael Koutsilieris
- Anastasia Evangelia Konstantinidou
View Affiliations

Affiliations: Fourth Obstetrics and Gynecology Department, ‘Elena Venizelou’ General Hospital of Athens, 11521 Athens, Greece, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece, Department of Physiology, Medical School, National Kapodistrian University of Athens, 11527 Athens, Greece, Department of Pathology, Aretaieion University Hospital, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece, Department of Pharmacy, School of Health Sciences, University of Patras, 26504 Patras, Greece, Department of Speech and Language Therapy, University of Ioannina, 45500 Ioannina, Greece
Published online on: January 9, 2025 https://doi.org/10.3892/mmr.2025.13434
Article Number: 69
Copyright: © Fasoulopoulos et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Intrauterine growth restriction (IUGR) is the second most common obstetric complication after preterm labor. Appropriate trophoblast differentiation and placental structure, growth and function are key for the maintenance of pregnancy and normal fetal growth, development and survival. Extravillous trophoblast cell proliferation, migration and invasion are regulated by molecules produced by the fetomaternal interface, including autocrine factors produced by the trophoblast, such as insulin‑like growth factor (IGF)‑1. The aim of the present study was to investigate expression patterns of IGF‑1Ea isoform in IUGR placenta compared with appropriate for gestational age (AGA) pregnancies. Placental frozen tissues were collected from 13 AGA and 15 IUGR third trimester pregnancies for detection of IGF‑1Ea mRNA expression using reverse transcription‑quantitative PCR. Formalin‑fixed paraffin‑embedded samples from 15 AGA and 47 IUGR pregnancies were analyzed immunohistochemically for the identification and localization of the IGF‑1Ea peptide and comparison of clinical and histopathological parameters. To the best of our knowledge, the present study is the first to show IGF‑1Ea expression in third trimester human placenta. The results indicated that similar IGF‑1Ea mRNA expression levels were present in placental specimens from both groups. Cytoplasmic IGF‑1Ea expression was localized in the perivillous syncytiotrophoblast, extravillous trophoblast and endothelium of the villous and decidual vessels in both groups. No significant difference in the scores and intensity of IGF‑1Ea expression in perivillous syncytiotrophoblasts were noted in the IUGR vs. AGA pregnancies. Most IUGR cases showed negative IGF‑1Ea expression in the extravillous trophoblast, whereas AGA pregnancies showed predominantly positive immunostaining. A sex‑specific expression pattern was noted in the extravillous trophoblast, with negative IGF‑1Ea expression in the placentas of female IUGR cases. Additionally, positive immunostaining for IGF‑1Ea peptide in fetal villous and maternal decidual vessels, was more frequently observed in the IUGR group compared with AGA. In conclusion, no difference in total IGF‑1Ea mRNA placental expression was observed between IUGR and AGA pregnancies, likely due to heterogeneity of histological structures expressing this isoform. Negative IGF‑1Ea immunohistological expression in the extravillous trophoblast from IUGR placentas, associated with histological changes of maternal malperfusion, may reflect the involvement of this isoform in defective placentation. The presence of IGF‑1Ea peptide in the endothelium of the villous vessels in IUGR placentas may indicate a reactive autocrine regulation to compensate for malperfused villi in IUGR pregnancy by regulating angiogenesis and vasodilation. The observed sex differences in IGF‑1Ea expression between IUGR and AGA placentas may indicate interactions between sex hormones and selective IGF‑1 binding proteins in regulating IGF‑1Ea synthesis; however, this requires further elucidation.

View Figures

View References

1	Hutter S, Hepp P, Hofmann S, Kuhn C, Messner J, Andergassen U, Mayr D, Solano ME, Obermeier V, Mahner S, et al: Glucocorticoid receptors α and β are modulated sex specifically in human placentas of intrauterine growth restriction (IUGR). Arch Gynecol Obstet. 300:323–335. 2019. View Article : Google Scholar : PubMed/NCBI
2	Morris RK, Johnston E, Lees C, Morton V and Smith G; Royal College of Obstetricians and Gynaecologists, : Investigation and care of a small-for-gestational-age fetus and a growth restricted fetus (Green-top Guideline No. 31). BJOG. 131:e31–e80. 2024. View Article : Google Scholar : PubMed/NCBI
3	Kamphof HD, Posthuma S, Gordijn SJ and Ganzevoort W: Fetal growth restriction: Mechanisms, epidemiology, and management. Matern Fetal Med. 4:186–196. 2022. View Article : Google Scholar
4	Suhag A and Berghella V: Intrauterine growth restriction (IUGR): Etiology and diagnosis. Curr Obstet Gynecol Rep. 2:102–111. 2013. View Article : Google Scholar : PubMed/NCBI
5	Nevo O, Many A, Xu J, Kingdom J, Piccoli E, Zamudio S, Post M, Bocking A, Tordos T and Caniggia I: Placental expression of soluble fms-like tyrosine kinase 1 is increased in singletons and twin pregnancies with intrauterine growth restriction. J Clin Endocrinol Metab. 93:285–292. 2008. View Article : Google Scholar : PubMed/NCBI
6	Aiko Y, Askew DJ, Aramaki S, Myoga M, Tomonaga C, Hachisuga T, Suga R, Kawamoto T, Tsuji M and Shibata E: Differential levels of amino acid transporters system L and ASCT2, and the mTOR protein in placenta of preeclampsia and IUGR. BMC Pregnancy Clidbirth. 14:1812014. View Article : Google Scholar : PubMed/NCBI
7	Menendez-Castro C, Rascher W and Hartner A: Intrauterine growth restriction-impact on cardiovascular diseases later in life. Mol Cell Pediatr. 5:42018. View Article : Google Scholar : PubMed/NCBI
8	Crispi F, Crovetto F and Gratacos E: Intrauterine growth restriction and later cardiovascular function. Early Hum Dev. 126:23–27. 2018. View Article : Google Scholar : PubMed/NCBI
9	Calek E, Binder J, Palmrich P, Eibensteiner F, Thajer A, Kainz T, Harreiter K, Berger A and Binder C: Effects of intrauterine growth restriction (IUGR) on growth and body composition compared to constitutionally small infancts. Nutrients. 15:41582023. View Article : Google Scholar : PubMed/NCBI
10	Novac MV, Niculescu M, Manolea MM, Dijmărescu AL, Iliescu DG, Novaac MB, Rotaru LT, Stonescu MF, Tabacu MC, Tudorache Ş, et al: Placental findings in pregnancies complicated with IUGR-histopathological and immunohistochemical analysis. Rom J Morphol Embryol. 59:715–720. 2018.PubMed/NCBI
11	Bartha JL, Romero-Carmona R and Comino-Delcado R: Inflammatory cytokines in intrauterine growth retardation. Acta Obstet Gynecol Scand. 82:1099–1102. 2003. View Article : Google Scholar : PubMed/NCBI
12	McKinnon T, Chakraborty C, Gleeson LM, Chidiac P and Lala PK: Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK. J Clin Endocrionol Metab. 86:3665–3674. 2001. View Article : Google Scholar
13	Horii M, Touma O, Bui T and Parast MM: Modeling human trophoblast, the placental epithelium at the maternal fetal interface. Reproduction. 160:R1–R11. 2020. View Article : Google Scholar : PubMed/NCBI
14	Lawless L, Qin Y, Xie L and Zhang K: Trophoblast differentiation: Mechanisms and implications for pregnancy complications. Nutrients. 15:35642023. View Article : Google Scholar : PubMed/NCBI
15	Qin J, Li W, Xue Z and Xue J: Early differentiation and gene expression characteristics of trophoblast lineages. Biol Reprod. 108:709–719. 2023. View Article : Google Scholar : PubMed/NCBI
16	Heazell AEP, Sharp AN, Baker PN and Crocker IP: Intra-uterine growth restriction is associated with increased apoptosis and altered expression of proteins in the p53 pathway in villous trophoblast. Apoptosis. 16:135–144. 2011. View Article : Google Scholar : PubMed/NCBI
17	Dietrich B, Kunihs V, Lackner AI, Meinhardt G, Koo BK, Pollheimer J, Haider S and Knöfler M: NOTCH3 signalling controls human trophoblast stem cell expansion and differentiation. Development. 150:dev2021522023. View Article : Google Scholar : PubMed/NCBI
18	Velicky P, Knöfler M and Pollheimer J: Function and control of human invasive trophoblast subtypes: Intrinsic vs maternal control. Cell Adh Migr. 10:154–162. 2016. View Article : Google Scholar : PubMed/NCBI
19	Staff AC, Fjeldstad HE, Fosheim IK, Moe K, Turowski G, Johnsen GM, Alnaes-Katjavivi P and Sugulle M: Failure of physiological transformation and spiral artery atherosis: Their roles in preeclampsia. Am J Obstet Gynecol. 226:S895–S906. 2022. View Article : Google Scholar : PubMed/NCBI
20	Lala PK and Nandi P: Mechanisms of trophoblast migration, endometrial angiogenesis in preeclampsia: The role of decorin. Cell Adh Mig. 10:111–125. 2016. View Article : Google Scholar : PubMed/NCBI
21	Lala PK and Graham CH: Editorial: Cellular and molecular determinants of pregnancy success at the fetal-maternal interface in health and disease. Front Cell Dev Biol. 11:12404812023. View Article : Google Scholar : PubMed/NCBI
22	Fuchs R and Ellinger I: Endocytic and transcytotic processes in villous syncytiotrophoblast: Role in nutrient transport to the human fetus. Traffic. 5:725–738. 2004. View Article : Google Scholar : PubMed/NCBI
23	Knöfler M, Haider S, Saleh L, Pollheimer J, Gamage TKJB and James J: Human placenta and trophoblast development: Key molecular mechanisms and model systems. Cell Mol Life Sci. 76:3479–3496. 2019. View Article : Google Scholar : PubMed/NCBI
24	Celik O, Saglam A, Baysal B, Derwig IE, Celik N, Ak M, Aslan SN, Ulas M, Ersahin A, Tayyar AT, et al: Factors preventing materno-fetal trasmission of SARS-CoV-2. Placenta. 97:1–5. 2020. View Article : Google Scholar : PubMed/NCBI
25	Coleman SJ, Gerza L, Jones CJP, Aplin JD and Heazell AEP: Syncytial nuclear aggregates in normal placenta show increased nuclear condensation, but apoptosis and cytoskeletal redistribution are uncommon. Placenta. 34:449–455. 2013. View Article : Google Scholar : PubMed/NCBI
26	Huppertz B and Kingdom JC: Apoptosis in the trophoblast-role of apoptosis in placental morphogenesis. J Soc Gynecol Invest. 11:353–362. 2004. View Article : Google Scholar : PubMed/NCBI
27	Calvert SJ, Longtime MS, Cotter S, Jones CJP, Sibley CP, Aplin JD, Nelson DM and Heazell AEP: Studies of the dynamics of nuclear clustering in human syncytiotrophoblast. Reproduction. 151:657–671. 2016. View Article : Google Scholar : PubMed/NCBI
28	Park SY, Kim MY, Kim YJ, Chun YK, Kim HS, Kim HS and Hong SR: Placental pathology in intrauterine growth retardation. Korea J Pathol. 36:30–37. 2002.
29	Corrêa RRM, Gilio DB, Cavellani CL, Paschoini MC, Oliveira FA, Peres LC, Reis MA, Teixeira VPA and Castro ECC: Placental morphometrical and histopathology changes in the different clinical presentations of hypertensive syndromes in pregnancy. Arch Gynecol Obstet. 277:201–206. 2008. View Article : Google Scholar : PubMed/NCBI
30	Resnik R: Intrauterine growth restriction. Obstet Gynecol. 99:490–496. 2002. View Article : Google Scholar : PubMed/NCBI
31	Sankaran S and Kyle PM: Aetiology and pathogenesis of IUGR. Best Pract Res Clin Obstet Gynaecol. 23:765–777. 2009. View Article : Google Scholar : PubMed/NCBI
32	Burnett B, Street L, Quinn K and Denney JM: Early onset fetal growth restriction: Does path to diagnosis impact outcomes and pathology? Arch Obstet Gynaecol. 1:5–12. 2020.PubMed/NCBI
33	Scifres CM and Nelson DM: Intrauterine growth restriction, human placental development and trophoblast cell death. J Physiol. 587:3453–3458. 2009. View Article : Google Scholar : PubMed/NCBI
34	Roland CS, Hu J, Ren CE, Chen H, Li J, Varvoutis MS, Leaphart LW, Byck DB, Zhu X and Jiang SW: Morphological changes of placental syncytium and their implications for the pathogenesis of preeclampsia. Cell Mol Life Sci. 73:365–376. 2016. View Article : Google Scholar : PubMed/NCBI
35	Zhou H, Zha C, Wang P, Yang W, Zhu H and Zhang S: Regulators involved in trophoblast syncytialization in the placenta of intrauterine growth restriction. Front Endocrinol (Lausanne). 14:11071822023. View Article : Google Scholar : PubMed/NCBI
36	Carter AM: Maintaining the integrity of trophoblast during growth of the placenta. Focus on ‘Insulin-like growth factor I and II regulate the life cycle of trophoblast in the developing human placenta’. Am J Physiol Cell Physiol. 294:C1303–C1304. 2008. View Article : Google Scholar : PubMed/NCBI
37	Pérez-Pérez A, Toro A, Vilariño-García T, Maymó J, Guadix P, Dueñas JL, Fernández-Sánchez M, Varone C and Sánchez-Margalet V: Leptin action in normal and pathological pregnancies. J Cell Mol Med. 22:716–727. 2018. View Article : Google Scholar : PubMed/NCBI
38	Forbes K, Westwood M, Baker PN and Aplin JD: Insulin-like growth factor I and II regulate the life cycle of trophoblast in the developing human placenta. Am J Physiol Cell Physiol. 294:C1313–C1322. 2008. View Article : Google Scholar : PubMed/NCBI
39	Dumolt JH, Powell TL and Jansson T: Placental function and the development of fetal overgrowth and fetal growth restriction. Obstet Gynecol Clin North Am. 48:247–266. 2021. View Article : Google Scholar : PubMed/NCBI
40	Lee MH, Jeon YJ, Lee SM, Park MH, Jung SC and Kim YJ: Placental gene expression is related to glucose metabolism and fetal cord blood levels of insulin and insulin-like growth factors in intrauterine growth restriction. Early Hum Dev. 86:45–50. 2010. View Article : Google Scholar : PubMed/NCBI
41	Giabicani E, Chantot-Bastaraud S, Bonnard A, Rachid M, Whalen S, Netchine I and Brioude F: Roles of type 1 insulin-like growth factor (IGF) receptor and IGF-II in growth regulation: Evidence from a patient carrying both an 11p paternal dublication and 15q deletion. Front Endocrinol (Lausanne). 10:2632019. View Article : Google Scholar : PubMed/NCBI
42	LeRoith D, Werner H, Beitner-Johnson D and Roberts C Jr: Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev. 16:143–163. 1995. View Article : Google Scholar : PubMed/NCBI
43	Schmid C: Insulin-like growth factors. Cell Biol Int. 19:445–457. 1995. View Article : Google Scholar : PubMed/NCBI
44	Bowman CJ, Steck RD and Chapin RE: Maternal-placental insulin-like growth factor (IGF) signaling and its importance to normal embryo-fetal development. Birth Defects Res B Dev Reprod Toxicol. 89:339–349. 2010. View Article : Google Scholar : PubMed/NCBI
45	Kasprzak A and Szaflaski W: Role of alternatively spliced messenger RNA (mRNA) isoforms of the insulin-like growth factor 1 (IGF1) in selected human tumors. Int J Mol Sci. 21:69952020. View Article : Google Scholar : PubMed/NCBI
46	Stavropoulos A, Varras M, Philippou A, Vasilakaki T, Varra VK, Varra FN, Tsavari A, Lazaris AC and Koutsilieris M: Immunohistochemical expression of insulin-like growth factor-1Ec in primary endometrial carcinoma: Association with PTEN, p53 and survivin expression. Oncol Lett. 20:3952020. View Article : Google Scholar : PubMed/NCBI
47	Milingos DS, Philippou A, Armakolas A, Papageorgiou E, Sourla A, Protopapas A, Liapi A, Antsaklis A, Mastrominas M and Koutsilieris M: Insulinlike growth factor-1Ec (MGF) expression in eutopic and ectopic endometrium: Characterization of the MGF E-peptide actions in vitro. Mol Med. 17:21–28. 2011. View Article : Google Scholar : PubMed/NCBI
48	Gkioka E, Msaouel P, Philippou A, Vlachogiannis NI, Voskou CT, Margiolis A and Koutsilieris M: Review: The role of insulin-like growth factor-1 signaling pathways in uterine leiomyoma. In Vivo. 29:637–649. 2015.PubMed/NCBI
49	Blontzos N, Mavrogianni D, Ntzeros K, Kathopoulis N, Moustogiannis A, Philippou A, Koutsilieris M and Protopapas A: Differential expression of insulin growth factor 1 (IGF-1) isoforms in different types of endometriosis: Preliminary results of a single-center study. Biomolecules. 14:72023. View Article : Google Scholar : PubMed/NCBI
50	Khong TY, Mooney EE, Ariel I, Balmus NCM, Boyd TK, Brundler MA, Derricott H, Evans MJ, Faye-Petersen OM, Gillan JE, et al: Sampling and definitions of placental lesions: Amsterdam placental workshop group consensus statement. Arch Pathol Lab Med. 140:698–713. 2016. View Article : Google Scholar : PubMed/NCBI
51	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using realtime quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
52	Scotlandi K and Belfiore A: Targeting the insulin-like growth factor (IGF) system is not as simple as just targeting the type 1 IGF receptor. Am Soc Clin Oncol Educ Book. 2012:599–604. 2012. View Article : Google Scholar : PubMed/NCBI
53	Griffeth RJ, Bianda V and Nef S: The emerging role of insulin-like growth factors in testis development and function. Basic Clin Androl. 24:122014. View Article : Google Scholar : PubMed/NCBI
54	Nawathe AR, Christian M, Kim SH, Johnson M, Savvidou MD and Terzidou V: Insulin-like growth factor axis in pregnancies affected by fetal growth disorders. Clin Epigenetics. 8:112016. View Article : Google Scholar : PubMed/NCBI
55	LeRoith D, Holly JMP and Forbes BE: Insulin-like growth factors: Ligands, binding proteins, and receptors. Mol Metab. 52:1012452021. View Article : Google Scholar : PubMed/NCBI
56	Werner H: The IGF1 signaling pathway: From basic concepts to therapeutic opportunities. Int J Mol Sci. 24:148822023. View Article : Google Scholar : PubMed/NCBI
57	Philippou A, Halapas A, Maridaki M and Koutsilieris M: Type I insulin-like growth factor receptor signaling in skeletal muscle regeneration and hypertrophy. J Musculoskelet Neuronal Interact. 7:208–218. 2007.PubMed/NCBI
58	Philippou A, Maridaki M, Pneumaticos S and Koutsilieris M: The complexity of the IGF1 gene splicing, posttranslational modification and bioactivity. Mol Med. 20:202–214. 2014. View Article : Google Scholar : PubMed/NCBI
59	Gong H, Wang H, Wang L, Liu Y, Wang J, Lv Q, Pang H, Zhang Q and Wang Z: Inhibition of IGF-1 receptor kinase blocks the differentiation into cardiomyocyte-like cells of BMSCs induced by IGF-1. Mol Med Rep. 16:787–793. 2017. View Article : Google Scholar : PubMed/NCBI
60	Philippou A, Maridaki M, Halapas A and Koutsilieris M: The role of the insulin-like growth factor 1 (IGF-1) in skeletal muscle physiology. In Vivo. 21:45–54. 2007.PubMed/NCBI
61	Annibalini G, Bielli P, De Santi M, Agostini D, Guescini M, Sisti D, Contarelli S, Brandi G, Villarini A, Stocchi V, et al: MIR retroposon exonization promotes evolutionary variability and generates species-specific expression of IGF-1 splice variants. Biochim Biophys Acta. 1859:757–768. 2016. View Article : Google Scholar : PubMed/NCBI
62	Hede MS, Salimova E, Piszczek A, Perlas E, Winn N, Nastasi T and Rosenthal N: E-peptides control bioavailability of IGF-1. PLoS One. 7:e511522012. View Article : Google Scholar : PubMed/NCBI
63	Gallego-Colon E, Sampson RD, Sattler S, Schneider MD, Rosenthal N and Tonkin J: Cardiac-restricted IGF-1Ea overexpression reduces the early accumulation of inflammatory myeloid cells and mediates expression of extracellular matrix remodeling genes after myocardial infarction. Mediators Imflamm. 2015:4843572015. View Article : Google Scholar : PubMed/NCBI
64	Adamek A and Kasprzak A: Insulin-like growth factor (IGF) system in liver disease. Int J Mol Sci. 19:13082018. View Article : Google Scholar : PubMed/NCBI
65	Blum WF, Alherbish A, Alsagheir A, Awwa AE, Kaplan W, Koledova E and Savage MO: The growth hormone-insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders. Endocr Connect. 7:R212–R222. 2018. View Article : Google Scholar : PubMed/NCBI
66	Karagiannis AK, Philippou A, Tseleni-Balafouta S, Zevolis E, Nakouti T, Tsopanomichalou-Gklotsou M, Psarras V and Koutsilieris M: IGF-IEc expression is associated with advanced differentiated thyroid cancer. Anticancer Res. 39:2811–2819. 2019. View Article : Google Scholar : PubMed/NCBI
67	Philippou A, Papageorgiou E, Bogdanis G, Halapas A, Sourla A, Maridaki M, Pissimissis N and Koutsilieris M: Expression of IGF-1 isoforms after exercise-induced muscle damage in humans: Characterization of the MGF E peptide actions in vitro. In Vivo. 23:567–575. 2009.PubMed/NCBI
68	Ahtiainen JP, Hulmi JJ, Lehti M, Kraemer WJ, Nyman K, Selänne H, Alen M, Komulainen J, Kovanen V, Mero AA, et al: Effects of resistance training on expression of IGF-I splice variants in younger and older men. Eur J Sport Sci. 16:1055–1063. 2016. View Article : Google Scholar : PubMed/NCBI
69	Bikle DD, Tahimic C, Chang W, Wang Y, Philippou A and Barton ER: Role of IGF-I signaling in muscle bone interactions. Bone. 80:79–88. 2015. View Article : Google Scholar : PubMed/NCBI
70	Christopoulos PF, Philippou A and Koutsilieris M: Pattern of IGF-1 variants' expression in human cancer cell lines using a novel q-RT-PCR approach. Anticancer Res. 35:107–115. 2015.PubMed/NCBI
71	Philippou A, Armakolas A and Koutsilieris M: Evidence for the possible biological significance of the igf-1 gene alternative splicing in prostate cancer. Front Endocrinol (Lausanne). 4:312013. View Article : Google Scholar : PubMed/NCBI
72	Martina NA, Kim E, Chitkara U, Wathen NC, Chard T and Giudice LC: Gestational age-dependent expression of insulin-like growth factor-binding protein-1 (IGFBP-1) phosphoisoforms in human extraembryonic cavities, maternal serum, and decidua suggests decidua as the primary source of IGFBP-1 in these fluids during early pregnancy. J Clin Endocrinol Metab. 82:1894–1898. 1997. View Article : Google Scholar : PubMed/NCBI
73	Han VK and Certer AM: Spatial and temporal patterns of expression of messenger RNA for insulin-like growth factors and their binding proteins in the placenta of man and laboratory animals. Placenta. 21:289–305. 2000. View Article : Google Scholar : PubMed/NCBI
74	Gupta MB: The role and regulation of IGFBP-1 phosphorylation in fetal growth restriction. J Cell Commun Signal. 9:111–123. 2015. View Article : Google Scholar : PubMed/NCBI
75	Malkani N, Biggar K, Shahab MA, Li SS, Jansson T and Gupta MB: Increased IGFBP-1 phosphorylation in response to leucine deprivation is mediated by CK2 and PKC. Mol Cell Endocrinol. 425:48–60. 2016. View Article : Google Scholar : PubMed/NCBI
76	Shehab MA, Biggar K, Kakadia JH, Dhruv M, Jain B, Nandi P, Nygard K, Jansson T and Gupta MB: Inhibition of decidual IGF-1 signaling in response to hypoxia and leucine deprivation is mediated by mTOR and AAR pathways and increased IGFBP-1 phosphorylation. Mol Cell Endocrinol. 512:1108652020. View Article : Google Scholar : PubMed/NCBI
77	Ashton IK, Zapf J, Einschenk I and MacKenzie IZ: Insulin-like growth factors (IGF) 1 and 2 in human foetal plasma and relationship to gestational age and foetal size during midpregnancy. Acta Endocrinol (Norway). 110:558–563. 1985.PubMed/NCBI
78	Giudice LC, de Zegher F, Gargosky SE, Dsupin BA, de las Fuentes L, Crystal RA, Hintz RL and Rosenfeld RG: Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab. 80:1548–1555. 1995. View Article : Google Scholar : PubMed/NCBI
79	Ong K, Kratzsch J, Kiess W, Costello M, Scott C and Dunger D: Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants. The ALSPAC study team. Avon longitudinal study of pregnancy and childhood. J Clin Endocrinol Metab. 85:4266–4269. 2000. View Article : Google Scholar : PubMed/NCBI
80	Luo ZC, Nuyt AM, Delvin E, Audibert F, Girard I, Shatenstein B, Cloutier A, Cousineau J, Djemli A, Deal C, et al: Maternal and fetal IGF-I and IGF-II levels, fetal growth, and gestational diabetes. J Clin Endocrinol Metab. 97:1720–1728. 2012. View Article : Google Scholar : PubMed/NCBI
81	Soliman A, Hamed N, Alyafei F, Alaaraj N, Ahmad S, Itani M and Soliman N: Insulin like growth factor 1 (IGF-1) and IGF binding proteins in obese pregnant women and their babies: Potential effects on placental function and fetal growth. World J Adv Res Rev. 17:93–100. 2023. View Article : Google Scholar
82	Olausson H, Löf M, Brismar K, Forsum E and Sohlström A: Maternal serum concentrations of insulin-like growth factor (IGF)-I and IGF binding protein-1 before and during pregnancy in relation to maternal body weight and composition and infant birth weight. Br J Nutr. 104:842–848. 2010. View Article : Google Scholar : PubMed/NCBI
83	Chassen S and Jansson T: Complex, coordinated and highly regulated changes in placental signaling and nutrient transport capacity in IUGR. Biochim Biophys Acta Mol Basis Dis. 1866:1653732020. View Article : Google Scholar : PubMed/NCBI
84	Wang HS, Lim J, English J, Irvine L and Chard T: The concentration of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in human umbilical cord serum at delivery: Relation to fetal weight. J Endocrinol. 129:459–464. 1991. View Article : Google Scholar : PubMed/NCBI
85	Tapanainen PJ, Bang P, Wilson K, Unterman TG, Vreman HJ and Rosenfeld RG: Maternal hypoxia as a model for intrauterine growth retardation: Effects on insulin-like growth factors and their binding proteins. Pediatr Res. 36:152–158. 1994. View Article : Google Scholar : PubMed/NCBI
86	Verhaeghe J, Van Herck E, Billen J, Moerman P, Van Assche FA and Giudice LC: Regulation of insulin-like growth factor-I and insulin-like growth factor binding protein-1 concentrations in preterm fetuses. Am J Obstet Gynecol. 188:485–491. 2003. View Article : Google Scholar : PubMed/NCBI
87	Dalçik H, Yardimoğlu M, Vural B, Dalçik C, Filiz S, Gonca S, Köktürk S and Ceylan S: Expression of insulin-like growth factor in the placenta of intrauterine growth-retarded human fetuses. Acta Histochem. 103:195–207. 2001. View Article : Google Scholar : PubMed/NCBI
88	Sheikh S, Satoskar P and Bhartiya D: Expression of insulin-like growth factor-I and placental growth hormone mRNA in placentae: A comparison between normal and intrauterine growth retardation pregnancies. Mol Hum Reprod. 7:287–292. 2001. View Article : Google Scholar : PubMed/NCBI
89	Ozkan S, Vural B, Dalçik C, Taş A and Dalçik H: Placental expression of insulin-like growth factor-I, fibroblast growth factor-basic and neural cell adhesion molecule in pregnancies with small for gestational age fetuses. J Perinatol. 28:468–474. 2008. View Article : Google Scholar : PubMed/NCBI
90	Calvo MT, Romo A, Gutiérrez JJ, Relaño E, Barrio E and Ferrández Longás A: Study of genetic expression of intrauterine growth factors IGF-I and EGFR in placental tissue from pregnancies with intrauterine growth retardation. J Pediatr Endocrinol Metab. 17 (Suppl 3):S445–S450. 2004.
91	Koutsaki M, Sifakis S, Zaravinos A, Koutroulakis D, Koukoura O and Spandidos DA: Decreased placental expression of hPGH, IGF-I and IGFBP-1 in pregnancies complicated by fetal growth restriction. Growth Horm IGF Res. 21:31–36. 2011. View Article : Google Scholar : PubMed/NCBI
92	Laviola L, Perrini S, Belsanti G, Natalicchio A, Montrone C, Leonardini A, Vimercati A, Scioscia M, Selvaggi L, Giorgino R, et al: Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling. Endocrinology. 166:1498–1505. 2005. View Article : Google Scholar : PubMed/NCBI
93	Yung HW, Calabrese S, Hynx D, Hemmings BA, Cetin I, Charnock-Jones DS and Burton GJ: Evidence of placental translation inhibition and endoplasmic reticulum stress in the etiology of human intrauterine growth restriction. Am J Pathol. 173:451–462. 2008. View Article : Google Scholar : PubMed/NCBI
94	Street ME, Viani I, Ziveri MA, Volta C, Smerieri A and Bernasconi S: Impairment of insulin receptor signal transduction in placentas of intra-uterine growth-restricted newborns and its relationship with fetal growth. Eur J Endocrinol. 164:45–52. 2011. View Article : Google Scholar : PubMed/NCBI
95	Abu-Amero SN, Ali Z, Bennett P, Vaughan JI and Moore GE: Expression of the insulin-like growth factors and their receptors in term placentas: A comparison between normal and IUGR births. Mol Reprod Dev. 49:229–235. 1998. View Article : Google Scholar : PubMed/NCBI
96	Milingos D, Katopodis H, Milingos S, Protopapas A, Creatsas G, Michalas S, Antsaklis A and Koutsilieris M: Insulin-like growth factor-1 isoform mRNA expression in women with endometriosis: Eutopic endometrium versus endometriotic cyst. Ann N Y Acad Sci. 1092:434–439. 2006. View Article : Google Scholar : PubMed/NCBI
97	Mekinian Α, Kolanska Κ, Cheloufi Μ, Coulomb Α, Cohen J, Abisror N, Bornes M, Kayem G, Alijotas-Reig J and Fain O: Chronic villitis of unknown etiology (VUE): Obstetrical features, outcome and treatment. J Reprod Immunol. 148:1034382021. View Article : Google Scholar : PubMed/NCBI
98	Nordenvall M and Sandstedt B: Placental villitis and intrauterine growth retardation in a Swedish population. APMIS. 98:19–24. 1990. View Article : Google Scholar : PubMed/NCBI
99	Martín-Estal I, de la Garza RG and Castilla-Cortázar I: Intrauterine growth retardation (IUGR) as a novel condition of insulin-like growth factor-1 (IGF-1) deficiency. Reviews of Physiology, Biochemistry and Pharmacology. Vol. 170. Nilius B, de Tombe P, Gudermann T, Jahn R, Lill R and Petersen O: Reviews of Physiology, Biochemistry and Pharmacology; vol 170. Springer, Cham: pp. 1–35. 2016, View Article : Google Scholar : PubMed/NCBI
100	Leung KC, Johannsson G, Leong GM and Ho KKY: Estrogen regulation of growth hormone action. Endocr Rev. 25:693–721. 2004. View Article : Google Scholar : PubMed/NCBI
101	Isotton AL, Wender MCO, Casagrande A, Rollin G and Czepielewski MA: Effects of oral and transdermal estrogen on IGF1, IGFBP3, IGFBP1, serum lipids, and glucose in patients with hypopituitarism during GH treatment: A randomized study. Eur J Endocrinol. 166:207–213. 2012. View Article : Google Scholar : PubMed/NCBI
102	Yoshizawa A and Clemmons DR: Testosterone and insulin-like growth factor (IGF) I interact in controlling IGF-binding protein production in androgen-responsive foreskin fibroblasts. J Clin Endocrinol Metab. 85:1627–1633. 2000. View Article : Google Scholar : PubMed/NCBI
103	Li X, Yu B, Wu X, Zhang J, Jia C, Wang Z, Zhou Q, Zhou H, Yi G, Chen X and Fu S: Associations between placental insulin-like growth factor-1 gene expression, DNA methylation and intrauterine growth restriction. Health. 12:270–280. 2020. View Article : Google Scholar
104	Wei XW, Zhang YC, Wu F, Tian FJ and Lin Y: The role of extravillous trophoblasts and uterine NK cells in vascular remodeling during pregnancy. Front Immunol. 13:9514822022. View Article : Google Scholar : PubMed/NCBI
105	Cho YL, Hur SM, Kim JY, Kim JH, Lee DK, Choe J, Won MH, Ha KS, Jeoung D, Han S, et al: Specific activation of insulin-like growth factor-1 receptor by ginsenoside Rg5 promotes angiogenesis and vasorelaxation. J Biol Chem. 290:467–477. 2015. View Article : Google Scholar : PubMed/NCBI
106	Lin S, Zhang Q, Shao X, Zhang T, Xue C, Shi S, Zhao D and Lin Y: IGF-1 promotes angiogenesis in endothelial cells/adipose-derived stem cells co-culture system with activation of PI3K/Akt signal pathway. Cell Prolif. 50:e123902017. View Article : Google Scholar : PubMed/NCBI
107	Reinmuth N, Fan F, Liu W, Parikh AA, Stoeltzing O, Jung YD, Bucana CD, Radinsky R, Gallick GE and Ellis LM: Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer. Lab Invest. 82:1377–1389. 2002. View Article : Google Scholar : PubMed/NCBI
108	Slomiany MG and Rosenzweig SA: IGF-1-induced VEGF and IGFBP-3 secretion correlates with increased HIF-1 alpha expression and activity in retinal pigment epithelial cell line D407. Invest Ophthalmol Vis Sci. 45:2838–2847. 2004. View Article : Google Scholar : PubMed/NCBI
109	Ferrara N and Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev. 18:4–25. 1997. View Article : Google Scholar : PubMed/NCBI
110	Saltiel AR and Kahn CR: Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 414:799–806. 2001. View Article : Google Scholar : PubMed/NCBI
111	Kondo T, Vicent D, Suzuma K, Yanagisawa M, King GL, Holzenberger M and Kahn CR: Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. J Clin Invest. 111:1835–1842. 2003. View Article : Google Scholar : PubMed/NCBI
112	Arjunan A, Sah DK, Woo M and Song J: Identification of the molecular mechanism of insulin-like growth factor-1 (IGF-1): A promising therapeutic target for neurodegenerative diseases associated with metabolic syndrome. Cell Biosci. 13:162023. View Article : Google Scholar : PubMed/NCBI
113	Laschke MW, Kontaxi E, Scheuer C, Heß A, Karscnia P and Menger MD: Insulin-like growth factor 1 stimulates the angiogenic activity of adipose tissue-derived microvascular fragments. J Tissue Eng. 10:20417314198798372019. View Article : Google Scholar : PubMed/NCBI
114	Tsukahara H, Gordienko DV, Tonshoff B, Gelato MC and Goligorsky MS: Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney Int. 45:598–604. 1994. View Article : Google Scholar : PubMed/NCBI
115	Higashi Y, Gautam S, Delafontaine P and Sukhanov S: IGF-1 and cardiovascular disease. Growth Horm IGF Res. 45:6–16. 2019. View Article : Google Scholar : PubMed/NCBI
116	Perticone F, Sciacqua A, Perticone M, Laino I, Miceli S, Carè I, Galiano Leone G, Andreozzi F, Maio R and Sesti G: Low-plasma insulin-like growth factor-I levels are associated with impaired endothelium-dependent vasodilatation in a cohort of untreated, hypertensive Caucasian subjects. J Clin Endocrinol Metab. 93:2806–2810. 2008. View Article : Google Scholar : PubMed/NCBI
117	Imrie H, Viswambharan H, Sukumar P, Abbas A, Cubbon RM, Yuldasheva N, Gage M, Smith J, Galloway S, Skromna A, et al: Novel role of the IGF-1 receptor in endothelial function and repair: Studies in endothelium-targeted IGF-1 receptor trangenic mice. Diabetes. 61:2359–2368. 2012. View Article : Google Scholar : PubMed/NCBI
118	Li H, Huang Q, Liu Y and Garmire LX: Single cell transcriptome research in human placenta. Reproduction. 160:R155–R167. 2000. View Article : Google Scholar : PubMed/NCBI